Regulated secretion is impaired in AtT-20 endocrine cells stably transfected with botulinum neurotoxin type A light chain
| dc.contributor.author | Aguado Tomàs, Fernando | |
| dc.contributor.author | Gombau, Lourdes | |
| dc.contributor.author | Majó, Glòria | |
| dc.contributor.author | Marsal Tebé, Jordi | |
| dc.contributor.author | Blanco Fernández, Jerónimo | |
| dc.contributor.author | Blasi Cabús, Joan | |
| dc.date.accessioned | 2021-05-25T16:43:05Z | |
| dc.date.available | 2021-05-25T16:43:05Z | |
| dc.date.issued | 1997-10-10 | |
| dc.date.updated | 2021-05-25T16:43:05Z | |
| dc.description.abstract | Botulinum neurotoxin type A (BoNT/A) inhibits neurotransmitter release by specific cleavage of SNAP-25, a synaptosome-associated protein also expressed in the ACTH secretory cell line AtT-20. Expression of light chain BoNT/A (L-BoNT/A) gene transfected into AtT-20 cells resulted in a cleaved form of SNAP-25 indistinguishable from that generated by bona fide BoNT/A. L-BoNT/A-transfected cells showed no difference in replication rate, viability, or phenotype, compared with control AtT-20 cells. In contrast, L-BoNT/A-transfected cells could not be induced to secrete ACTH upon stimulation by 8-bromo-cAMP or KCl. In addition, alpha-latrotoxin induced ACTH release from control cells, but not from L-BoNT/A-transfected cells. These experiments suggest an important role for SNAP-25 in regulated secretion from AtT-20 cells and underline the usefulness of this cell system as a tool for the study of the molecular mechanism of peptide hormone secretion. | |
| dc.format.extent | 4 p. | |
| dc.format.mimetype | application/pdf | |
| dc.identifier.idgrec | 130366 | |
| dc.identifier.issn | 0021-9258 | |
| dc.identifier.pmid | 9325336 | |
| dc.identifier.uri | https://hdl.handle.net/2445/177587 | |
| dc.language.iso | eng | |
| dc.publisher | American Society for Biochemistry and Molecular Biology | |
| dc.relation.isformatof | Reproducció del document publicat a: https://doi.org/10.1074/jbc.272.41.26005 | |
| dc.relation.ispartof | Journal of Biological Chemistry, 1997, vol. 272, num. 41, p. 26005-26008 | |
| dc.relation.uri | https://doi.org/10.1074/jbc.272.41.26005 | |
| dc.rights | (c) American Society for Biochemistry and Molecular Biology, 1997 | |
| dc.rights.accessRights | info:eu-repo/semantics/openAccess | |
| dc.source | Articles publicats en revistes (Patologia i Terapèutica Experimental) | |
| dc.subject.classification | Toxina botulínica | |
| dc.subject.classification | Proteïnes de membrana | |
| dc.subject.classification | Teixit nerviós | |
| dc.subject.classification | Hormones pituïtàries | |
| dc.subject.other | Botulinum toxin | |
| dc.subject.other | Membrane proteins | |
| dc.subject.other | Nerve tissue | |
| dc.subject.other | Pituitary hormones | |
| dc.title | Regulated secretion is impaired in AtT-20 endocrine cells stably transfected with botulinum neurotoxin type A light chain | |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:eu-repo/semantics/publishedVersion |
Fitxers
Paquet original
1 - 1 de 1